Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $11.01B.
ENTERPRISE VALUE (EV)
$11.01B
Bruker Corporation
Market Cap
$9.57B
Enterprise Value (EV)
$11.01B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Bruker Corporation (BRKRP) | $9.57B | $11.01B |
| Insulet Corp. (PODD)vs › | $9.39B | $9.81B |
| Henry Schein, Inc. (HSIC)vs › | $9.76B | $13.42B |
| Krystal Biotech, Inc. (KRYS)vs › | $9.78B | $9.36B |
| The Ensign Group, Inc. (ENSG)vs › | $9.95B | $11.94B |
| Bruker Corporation (BRKR)vs › | $10.00B | $11.73B |
| Caris Life Sciences, Inc. (CAI)vs › | $9.08B | $8.84B |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.98B | $8.88B |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.97B | $8.93B |
| Molina Healthcare, Inc. (MOH)vs › | $10.16B | $9.13B |
Market Cap
$9.57B
Total Debt
$1.75B
Cash
$298.80M
Enterprise Value
$11.01B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
